MyAverix Finance
US · Healthcare
Quince Therapeutics, Inc. (QNCX)
Biotechnology
Quince Therapeutics, Inc. (QNCX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $21.52M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for QNCX
Quince Therapeutics, Inc. (QNCX) — FAQ
What is Quince Therapeutics, Inc.'s market cap?
Quince Therapeutics, Inc. (QNCX) has a reported market cap of $21.52M (data as of 2026-05-24).
What is QNCX's P/E ratio?
The price-to-earnings (P/E) ratio for Quince Therapeutics, Inc. (QNCX) is 25.00 (data as of 2026-05-24).
Does Quince Therapeutics, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Quince Therapeutics, Inc. (QNCX). Check the MyAverix Finance app for the latest dividend data.
What sector is Quince Therapeutics, Inc. in?
Quince Therapeutics, Inc. (QNCX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is QNCX listed on?
QNCX is listed on US.
What is Quince Therapeutics, Inc.'s net margin?
Quince Therapeutics, Inc. (QNCX) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.